Advisory Committees

February 27, 2013: Vaccines and Related Biological Products Advisory Committee Final Agenda

FOOD AND DRUG ADMINISTRATION
Center for Biologics Evaluation and Research
132nd Meeting of the Vaccines and Related Biological Products Advisory Committee
NIH Fishers Lane Conference Center
Terrace Level, Rooms 508-510, 5635 Fishers Lane
Rockville, Maryland
February 27, 2013

AGENDA

Open Session
8:30 a.m.

Call to Order and Opening Remarks
Conflict of Interest Statement

Robert Daum, M.D., Chair
Donald Jehn, M.S., FDA

Topic 1:
Strain Selection for the Influenza Virus Vaccine for the 2013-2014 Influenza Season
8:45IntroductionJerry Weir, Ph.D.
Director
Division of Viral Products
OVRR/CBER/FDA
8:55U.S. Surveillance: Influenza Activity Update:
2012-13 Season
Lyn Finelli, DrPH, MS
Lead, Influenza Surveillance and
Outbreak Response Team
Influenza Division, NCIRD
CDC
9:15World Surveillance/Virus CharacterizationNancy Cox, Ph.D.
Director, Influenza Division
Director, WHO Collaborating Center
For Surveillance, Epidemiology &
Control of Influenza,
National Center for Immunization &
Respiratory Diseases, CDC
10:00Break 
10:15DoD Vaccine Effectiveness ReportCDR Michael J. Cooper
USPHS MEDCOM
Armed Forces Health Surveillance
Center
10:35Vaccine ResponsesZhiping Ye, M.D., Ph.D.
Senior Investigator
Division of Viral Products
OVRR/CBER/FDA
10:55Availability of Vaccine Viruses & Reagents 

Manju Joshi, Ph.D.
Lead Biologist
Division of Biological Standards &
Quality Control, OCBQ/CBER/FDA

11:15Comments from ManufacturersKathleen Coelingh, Ph.D.
Senior Director,
Medical and Scientific Affairs
MedImmune
11:35Lunch 
12:35 pmOpen Public Hearing 
1:35Committee Discussion and Recommendations 
2:45Adjournment 

Page Last Updated: 08/14/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.